CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Achieve Life Sciences, Inc. - ACHV CFD

4.91
1.64%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.27
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 4.87
开盘价* 4.88
1 年变化* -1.21%
日范围* 4.79 - 4.95
52 周范围 2.00-8.13
平均交易量（10 天） 104.67K
平均交易量（3 个月) 2.11M
市值 78.54M
市盈率 -100.00K
流通股 17.93M
收入 N/A
EPS -4.06
股息（收益率 %） N/A
贝塔 1.46
下一个财报发布日期 May 10, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Jun 29, 2022 4.91 0.03 0.61% 4.88 4.95 4.79
Jun 28, 2022 4.87 -0.23 -4.51% 5.10 5.20 4.85
Jun 27, 2022 5.10 0.02 0.39% 5.08 5.14 4.91
Jun 24, 2022 5.15 0.05 0.98% 5.10 5.24 5.00
Jun 23, 2022 5.06 -0.08 -1.56% 5.14 5.32 5.06
Jun 22, 2022 5.12 0.03 0.59% 5.09 5.37 5.09
Jun 21, 2022 5.29 -0.24 -4.34% 5.53 5.63 5.28
Jun 17, 2022 5.49 0.01 0.18% 5.48 5.69 5.34
Jun 16, 2022 5.48 -0.35 -6.00% 5.83 5.83 5.45
Jun 15, 2022 5.90 -0.05 -0.84% 5.95 6.07 5.82
Jun 14, 2022 5.94 -0.13 -2.14% 6.07 6.12 5.87
Jun 13, 2022 5.99 -0.22 -3.54% 6.21 6.25 5.92
Jun 10, 2022 6.39 -0.16 -2.44% 6.55 6.55 6.39
Jun 9, 2022 6.57 0.06 0.92% 6.51 6.63 6.51
Jun 8, 2022 6.58 0.19 2.97% 6.39 6.60 6.39
Jun 7, 2022 6.55 0.09 1.39% 6.46 6.62 6.39
Jun 6, 2022 6.47 -0.14 -2.12% 6.61 6.71 6.46
Jun 3, 2022 6.63 -0.03 -0.45% 6.66 6.74 6.56
Jun 2, 2022 6.60 0.04 0.61% 6.56 6.63 6.56
Jun 1, 2022 6.54 -0.23 -3.40% 6.77 6.80 6.42

Achieve Life Sciences, Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 0 0 0 0 0
收入
总营业费用 33.094 14.75 16.528 12.813 5.16
销售/一般/行政费用，总计 9.128 7.868 6.854 6.945 3.531
研究与开发 23.966 6.882 9.674 5.868 3.101
异常费用（收入） 0 0 -1.472
营业收入 -33.094 -14.75 -16.528 -12.813 -5.16
利息收入（费用），非经营净值 0.017 0.069 0.17 0.171 0.021
其他，净值 -0.075 -0.049 -0.037 -0.045 0.115
税前净收入 -33.152 -14.73 -16.395 -12.687 -13.634
税后净收入 -33.152 -14.73 -16.395 -12.687 -10.583
未计算非常项目前的净收益 -33.152 -14.73 -16.395 -12.687 -10.583
净收入 -33.152 -14.73 -16.395 -12.687 -10.583
普通股股东可获收益 (不含非经常性项目) -33.152 -14.73 -16.395 -12.687 -10.583
普通股股东可获收益 (含非經常性項目) -33.152 -14.73 -16.395 -12.687 -10.583
摊薄净收入 -33.152 -14.73 -16.395 -12.687 -10.583
摊薄后加权平均股 8.11984 2.71891 0.41232 0.17551 0.02397
扣除特别项目的每股摊薄盈利 -4.08284 -5.41761 -39.7628 -72.2861 -441.473
每股正常摊薄盈利 -4.08284 -5.41761 -39.7628 -72.2861 -247.927
Gain (Loss) on Sale of Assets 0 0 -8.61
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 0 0 0 0 0
总营业费用 7.226 7.115 6.693 11.302 7.984
销售/一般/行政费用，总计 2.838 2.609 2.102 2.075 2.342
研究与开发 4.388 4.506 4.591 9.227 5.642
营业收入 -7.226 -7.115 -6.693 -11.302 -7.984
利息收入（费用），非经营净值 -0.353 0.003 0.003 0.003 0.008
其他，净值 0.006 -0.039 -0.001 -0.012 -0.023
税前净收入 -7.573 -7.151 -6.691 -11.311 -7.999
税后净收入 -7.573 -7.151 -6.691 -11.311 -7.999
未计算非常项目前的净收益 -7.573 -7.151 -6.691 -11.311 -7.999
净收入 -7.573 -7.151 -6.691 -11.311 -7.999
普通股股东可获收益 (不含非经常性项目) -7.573 -7.151 -6.691 -11.311 -7.999
普通股股东可获收益 (含非經常性項目) -7.573 -7.151 -6.691 -11.311 -7.999
摊薄净收入 -7.573 -7.151 -6.691 -11.311 -7.999
摊薄后加权平均股 9.45875 9.4682 9.45224 7.3906 6.13182
扣除特别项目的每股摊薄盈利 -0.80063 -0.75527 -0.70787 -1.53046 -1.30451
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.80063 -0.75527 -0.70787 -1.53046 -1.30451
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 44.594 36.975 17.334 15.537 5.908
现金和短期投资 43.022 35.853 16.664 14.604 5.284
Cash
现金等价物 43.022 35.853 16.664 9.515 5.284
短期投资 5.089
应收账款总额，净额 0.153 0.008 0.007 0.009
Accounts Receivable - Trade, Net 0.008 0.007 0.009
Prepaid Expenses 1.419 1.122 0.662 0.926 0.393
Total Assets 47.516 40.298 21.078 19.084 9.892
Property/Plant/Equipment, Total - Net 0.079 0.188 0.386 0.035 0.059
Property/Plant/Equipment, Total - Gross 0.366 0.82 0.986 0.755 1.144
Accumulated Depreciation, Total -0.287 -0.632 -0.6 -0.72 -1.085
Other Long Term Assets, Total 0.168 0.237 0.237 0.168 0.359
Total Current Liabilities 4.55 2.935 2.869 3.27 2.013
Accounts Payable 0.841 0.332 0.859 0.144 0.213
Accrued Expenses 3.709 2.603 2.01 3.126 1.773
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.027
Other Current Liabilities, Total 0
Total Liabilities 19.474 3.012 3.028 3.282 2.013
Total Long Term Debt 14.92 0 0 0 0
Long Term Debt 14.92
Total Equity 28.042 37.286 18.05 15.802 7.879
Common Stock 0.079 0.076 0.041 0.018 0.012
Additional Paid-In Capital 121.545 97.64 63.709 41.161 20.556
Retained Earnings (Accumulated Deficit) -93.586 -60.434 -45.704 -25.381 -12.694
Other Equity, Total 0.004 0.004 0.004 0.004 0.005
Total Liabilities & Shareholders’ Equity 47.516 40.298 21.078 19.084 9.892
Total Common Shares Outstanding 9.45354 6.11174 1.47426 0.33606 0.05978
Other Current Assets, Total 0 0.222
Goodwill, Net 1.034 1.034 1.034 1.034 1.034
Intangibles, Net 1.641 1.864 2.087 2.31 2.532
Deferred Income Tax 0
Other Liabilities, Total 0.004 0.077 0.159 0.012
Total Preferred Shares Outstanding 0 0.00112 0.00058
Redeemable Preferred Stock 0 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 37.692 44.594 34.733 42.431 30.439
现金和短期投资 36.337 43.022 33.312 42.001 29.637
现金等价物 36.337 43.022 33.312 42.001 29.637
Prepaid Expenses 1.355 1.419 1.27 0.43 0.802
Total Assets 40.614 47.516 37.799 45.565 33.662
Property/Plant/Equipment, Total - Net 0.049 0.079 0.1 0.121 0.141
Goodwill, Net 1.034 1.034 1.034 1.034 1.034
Intangibles, Net 1.586 1.641 1.697 1.752 1.809
Other Long Term Assets, Total 0.253 0.168 0.235 0.227 0.239
Total Current Liabilities 4.01 4.55 3.076 4.67 3.515
Accounts Payable 0.418 0.841 0.815 0.575 0.585
Accrued Expenses 3.592 3.709 2.261 4.095 2.93
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 19.181 19.474 3.099 4.711 3.574
Total Long Term Debt 15.171 14.92 0 0 0
Other Liabilities, Total 0 0.004 0.023 0.041 0.059
Total Equity 21.433 28.042 34.7 40.854 30.088
Redeemable Preferred Stock 0
Common Stock 0.079 0.079 0.079 0.079 0.076
Additional Paid-In Capital 122.509 121.545 121.052 120.515 98.441
Retained Earnings (Accumulated Deficit) -101.159 -93.586 -86.435 -79.744 -68.433
Other Equity, Total 0.004 0.004 0.004 0.004 0.004
Total Liabilities & Shareholders’ Equity 40.614 47.516 37.799 45.565 33.662
Total Common Shares Outstanding 9.47358 9.45354 9.45354 9.45222 6.14992
Total Preferred Shares Outstanding 0 0
应收账款总额，净额 0 0.153 0.151
Long Term Debt 15.171 14.92
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -33.152 -14.73 -16.395 -12.687 -10.583
经营活动产生的现金 -29.44 -13.474 -15.216 -10.623 -9.107
经营活动产生的现金 0.027 0.032 0.031 0.06 0.059
非现金物品 2.228 1.286 1.198 0.854 7.336
营运资金的变化 1.234 -0.285 -0.273 0.928 -3.091
投资活动产生的现金 -0.017 5.036 -5.125 12.648
资本支出 -0.017 -0.053 -0.046
其他投资现金流量项目，总计 5.089 -5.079 12.648
融资活动产生的现金 36.61 32.68 17.325 19.757 2.001
融资现金流项目 27.87 12.334 4.96 1.937
股票的发行（报废），净额 21.681 4.81 4.991 14.797 0.064
外汇效应 -0.001 0.004 0 -0.001
现金净变化 7.169 19.189 7.149 4.009 5.541
Amortization 0.223 0.223 0.223 0.222 0.223
Deferred Taxes -3.051
债务的发行（退还），净额 14.929 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -7.573 -33.152 -26.001 -19.31 -7.999
Cash From Operating Activities -6.779 -29.44 -24.222 -15.528 -6.452
Cash From Operating Activities 0.25 0.188 0.127 0.064
Non-Cash Items 1.12 2.228 1.734 1.204 0.565
Changes in Working Capital -0.386 1.234 -0.143 2.451 0.918
Cash From Investing Activities 0 0 0
Capital Expenditures 0 0 0
Cash From Financing Activities 0.095 36.61 21.682 21.674 0.236
Issuance (Retirement) of Stock, Net 0.024 21.681 21.682 21.674 0.236
Net Change in Cash -6.685 7.169 -2.541 6.148 -6.216
Financing Cash Flow Items 0.071 0 0
Foreign Exchange Effects -0.001 -0.001 -0.001 0.002
Issuance (Retirement) of Debt, Net 14.929
Amortization 0.06
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
B. Riley Asset Management, LLC Investment Advisor/Hedge Fund 19.4865 3494000 0 2023-03-01 MED
Contrarian Alpha Management, L.L.C. Corporation 7.6288 1367873 1367873 2022-11-18
Francis Capital Management, LLC Hedge Fund 2.4117 432432 -161818 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.8976 340238 -8075 2022-12-31 LOW
Shay Capital LLC Hedge Fund 1.8962 340000 0 2022-12-31 HIGH
Long Focus Capital Management LLC Hedge Fund 1.7469 313220 5000 2022-12-31 MED
Perkins Capital Management, Inc. Investment Advisor 1.2164 218100 0 2022-12-31 LOW
LPL Financial LLC Investment Advisor 0.8271 148300 48400 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.7022 125910 -12000 2022-12-31 LOW
Raymond James & Associates, Inc. Research Firm 0.4978 89249 71818 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.4761 85365 -189 2022-12-31 LOW
Fichthorn (John) Individual Investor 0.3067 55000 0 2023-03-01 LOW
Citadel Advisors LLC Hedge Fund 0.283 50746 15746 2022-12-31 HIGH
Group One Trading, L.P. Research Firm 0.2751 49322 6861 2022-12-31 HIGH
Renaissance Technologies LLC Hedge Fund 0.2186 39200 500 2022-12-31 HIGH
Bencich (John A.) Individual Investor 0.2059 36920 22000 2022-11-18 MED
Diametric Capital Investment Advisor/Hedge Fund 0.1933 34660 15153 2022-09-30 HIGH
QS Investors, LLC Investment Advisor/Hedge Fund 0.1899 34050 33500 2021-06-30 LOW
Millennium Management LLC Hedge Fund 0.1697 30422 30422 2022-12-31 HIGH
Clearline Capital LP Hedge Fund 0.1515 27156 -92938 2022-12-31 HIGH

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Achieve Life Sciences, Inc. Company profile

关于 Achieve Life Sciences Inc.

Achieve Life Sciences, Inc.是一家处于临床阶段的制药公司。 公司从事用于戒烟和尼古丁成瘾的cytisinicline的开发和商业化工作。 公司的候选产品Cytisinicline是一种天然存在的植物性生物碱，来自Laburnum anagyroides植物的种子。 胞苷在结构上与尼古丁相似，其作用机制既是激动性的又是拮抗性的。 它通过与大脑中的尼古丁受体相互作用，通过对尼古丁受体的激动作用减少尼古丁戒断症状的严重程度，并通过拮抗作用减少与尼古丁相关的奖励和满足感，从而帮助戒烟或尼古丁成瘾。

Industry: Biotechnology & Medical Research (NEC)

22722 29Th Dr. Se
Suite 100
SEATTLE
WASHINGTON 98021
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

70.28 Price
+1.050% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

Gold

1,972.17 Price
+1.580% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

BTC/USD

27,414.05 Price
-2.720% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

XRP/USD

0.42 Price
-14.130% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00396

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易